Literature DB >> 10079110

Overexpression of a human potassium channel suppresses cardiac hyperexcitability in rabbit ventricular myocytes.

H B Nuss1, E Marbán, D C Johns.   

Abstract

The high incidence of sudden death in heart failure may reflect abnormalities of repolarization and heightened susceptibility to arrhythmogenic early afterdepolarizations (EADs). We hypothesized that overexpression of the human K+ channel HERG (human ether-a-go-go-related gene) could enhance repolarization and suppress EADs. Adult rabbit ventricular myocytes were maintained in primary culture, which suffices to prolong action potentials and predisposes to EADs. To achieve efficient gene transfer, we created AdHERG, a recombinant adenovirus containing the HERG gene driven by a Rous sarcoma virus (RSV) promoter. The virally expressed HERG current exhibited pharmacologic and kinetic properties like those of native IKr. Transient outward currents in AdHERG-infected myocytes were similar in magnitude to those in control cells, while stimulated action potentials (0.2 Hz, 37 degrees C) were abbreviated compared with controls. The occurrence of EADs during a train of action potentials was reduced by more than fourfold, and the relative refractory period was increased in AdHERG-infected myocytes compared with control cells. Gene transfer of delayed rectifier potassium channels represents a novel and effective strategy to suppress arrhythmias caused by unstable repolarization.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10079110      PMCID: PMC408140          DOI: 10.1172/JCI5073

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  48 in total

1.  Improved guinea-pig ventricular cell model incorporating a diadic space, IKr and IKs, and length- and tension-dependent processes.

Authors:  D Noble; A Varghese; P Kohl; P Noble
Journal:  Can J Cardiol       Date:  1998-01       Impact factor: 5.223

2.  Modulation of HERG affinity for E-4031 by [K+]o and C-type inactivation.

Authors:  S Wang; M J Morales; S Liu; H C Strauss; R L Rasmusson
Journal:  FEBS Lett       Date:  1997-11-03       Impact factor: 4.124

3.  Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature.

Authors:  Z Zhou; Q Gong; B Ye; Z Fan; J C Makielski; G A Robertson; C T January
Journal:  Biophys J       Date:  1998-01       Impact factor: 4.033

4.  Molecular mechanism and functional significance of the MinK control of the KvLQT1 channel activity.

Authors:  G Romey; B Attali; C Chouabe; I Abitbol; E Guillemare; J Barhanin; M Lazdunski
Journal:  J Biol Chem       Date:  1997-07-04       Impact factor: 5.157

5.  Rapid inactivation determines the rectification and [K+]o dependence of the rapid component of the delayed rectifier K+ current in cardiac cells.

Authors:  T Yang; D J Snyders; D M Roden
Journal:  Circ Res       Date:  1997-06       Impact factor: 17.367

6.  KvLQT1, a voltage-gated potassium channel responsible for human cardiac arrhythmias.

Authors:  W P Yang; P C Levesque; W A Little; M L Conder; F Y Shalaby; M A Blanar
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

7.  A minK-HERG complex regulates the cardiac potassium current I(Kr).

Authors:  T V McDonald; Z Yu; Z Ming; E Palma; M B Meyers; K W Wang; S A Goldstein; G I Fishman
Journal:  Nature       Date:  1997-07-17       Impact factor: 49.962

8.  Block of the rapid component of the delayed rectifier potassium current by the prokinetic agent cisapride underlies drug-related lengthening of the QT interval.

Authors:  B Drolet; M Khalifa; P Daleau; B A Hamelin; J Turgeon
Journal:  Circulation       Date:  1998-01-20       Impact factor: 29.690

9.  Four novel KVLQT1 and four novel HERG mutations in familial long-QT syndrome.

Authors:  T Tanaka; R Nagai; H Tomoike; S Takata; K Yano; K Yabuta; N Haneda; O Nakano; A Shibata; T Sawayama; H Kasai; Y Yazaki; Y Nakamura
Journal:  Circulation       Date:  1997-02-04       Impact factor: 29.690

10.  Facilitation of epinephrine-induced afterdepolarizations by class III antiarrhythmic drugs.

Authors:  E Patterson; B J Scherlag; B Szabo; R Lazzara
Journal:  J Electrocardiol       Date:  1997-07       Impact factor: 1.438

View more
  16 in total

Review 1.  Genetic basis for the origin of cardiac arrhythmias: implications for therapy.

Authors:  Mackenzi Mbai; Sridharan Rajamani; Brian P Delisle; Blake D Anson; Corey Anderson; Jonathan C Makielski; Craig T January
Journal:  Curr Cardiol Rep       Date:  2002-09       Impact factor: 2.931

Review 2.  Creating a cardiac pacemaker by gene therapy.

Authors:  Traian M Anghel; Steven M Pogwizd
Journal:  Med Biol Eng Comput       Date:  2006-12-01       Impact factor: 2.602

Review 3.  Creation of a biological pacemaker by gene- or cell-based approaches.

Authors:  Eduardo Marbán; Hee Cheol Cho
Journal:  Med Biol Eng Comput       Date:  2007-01-30       Impact factor: 2.602

4.  Distinct gene-specific mechanisms of arrhythmia revealed by cardiac gene transfer of two long QT disease genes, HERG and KCNE1.

Authors:  U C Hoppe; E Marbán; D C Johns
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

5.  A titratable two-step transcriptional amplification strategy for targeted gene therapy based on ligand-induced intramolecular folding of a mutant human estrogen receptor.

Authors:  Ian Y Chen; Ramasamy Paulmurugan; Carsten H Nielsen; David S Wang; Vinca Chow; Robert C Robbins; Sanjiv S Gambhir
Journal:  Mol Imaging Biol       Date:  2014-04       Impact factor: 3.488

Review 6.  Mechanisms of altered Ca²⁺ handling in heart failure.

Authors:  Min Luo; Mark E Anderson
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

7.  Spatial gradients in action potential duration created by regional magnetofection of hERG are a substrate for wavebreak and turbulent propagation in cardiomyocyte monolayers.

Authors:  Katherine Campbell; Conrado J Calvo; Sergey Mironov; Todd Herron; Omer Berenfeld; José Jalife
Journal:  J Physiol       Date:  2012-10-22       Impact factor: 5.182

Review 8.  The genomics of cardiovascular disorders: therapeutic implications.

Authors:  P Ferrari; G Bianchi
Journal:  Drugs       Date:  2000-05       Impact factor: 9.546

9.  Generation of murine cardiac pacemaker cell aggregates based on ES-cell-programming in combination with Myh6-promoter-selection.

Authors:  Christian Rimmbach; Julia J Jung; Robert David
Journal:  J Vis Exp       Date:  2015-02-17       Impact factor: 1.355

Review 10.  Targeting signaling pathways in heart failure by gene transfer.

Authors:  Briain D MacNeill; Motoya Hayase; Roger J Hajjar
Journal:  Curr Atheroscler Rep       Date:  2003-05       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.